Non-small Cell Carcinoma

19 clinical trials · Condition

Record	Firm	Date
Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients (NCT05319886)	The First Affiliated Hospital of Xinxiang Medical College	2022-05-16
Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint Blocker in NSCLC (NCT05007769)	Washington University School of Medicine	2021-10-31
Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer (NCT04791839)	Washington University School of Medicine	2021-08-04
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations (NCT04695925)	Li Zhang, MD	2021-03-29
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules (NCT04171492)	Biodesix, Inc.	2020-12-18
Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer (NCT04364048)	Rachel Sanborn	2020-06-18
Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NCT03991819)	University Health Network, Toronto	2019-09-20
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer (NCT02922764)	Inspirna, Inc.	2016-11-01
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer (NCT03394105)	Asan Medical Center	2016-07-26
Safety Study of SEA-CD40 in Cancer Patients (NCT02376699)	Seagen Inc.	2015-02-28
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer (NCT00073398)	NewLink Genetics Corporation	2003-11-01

Track Non-small Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.